Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Yanagisawa

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Japanese Journal of Pharmacology|January 1, 1995
Antisecretory and antiulcer effects of YM020, a new H+,K(+)-ATPase inhibitor, in rats and dogsH Yuki, T Kamato, A Nishida, et al.
Chemical & Pharmaceutical Bulletin|October 23, 1997
Synthesis of novel succinamide derivatives having a 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. IIT Watanabe, A Kakefuda, I Kinoyama, et al.
Biological & Pharmaceutical Bulletin|March 8, 2000
Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension modelsT Tokioka, M Shibasaki, A Fujimori, et al.
Chemical & Pharmaceutical Bulletin|July 11, 1998
Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivativesT Okazaki, T Watanabe, K Kikuchi, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1997
Synthesis of novel succinamide derivatives having the 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. IT Watanabe, I Kinoyama, A Kakefuda, et al.
Chemical & Pharmaceutical Bulletin|February 20, 1998
Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonistsT Watanabe, A Kakefuda, A Tanaka, et al.
Chemical & Pharmaceutical Bulletin|June 11, 1998
Studies on nonpeptide angiotensin II receptor antagonists. III. Synthesis and biological evaluation of 5-alkylidene-3,5-dihydro-4H-imidazol-4-one derivativesT Okazaki, K Kikuchi, T Watanabe, et al.
Chemical & Pharmaceutical Bulletin|August 6, 1999
Novel potassium channel activators. II. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: modification of the aromatic partY Matsumoto, R Tsuzuki, A Matsuhisa, et al.
Chemical & Pharmaceutical Bulletin|May 1, 1996
Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. II. Synthesis and structure-activity relationships of 4,5,6,7-tetrahydro-1H-benzimidazole derivativesM Ohta, T Suzuki, J Ohmori, et al.
Jinrui Idengaku Zasshi. the Japanese Journal of Human Genetics|December 1, 1989
The characterization of human male-specific 5.7 kb DNA(pKY-1) and its application to fetal sex-determination probeK Nagai, S Koike, R Kominami, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Japanese Journal of Pharmacology|January 1, 1995
Antisecretory and antiulcer effects of YM020, a new H+,K(+)-ATPase inhibitor, in rats and dogsH Yuki, T Kamato, A Nishida, et al.
Chemical & Pharmaceutical Bulletin|October 23, 1997
Synthesis of novel succinamide derivatives having a 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. IIT Watanabe, A Kakefuda, I Kinoyama, et al.
Biological & Pharmaceutical Bulletin|March 8, 2000
Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension modelsT Tokioka, M Shibasaki, A Fujimori, et al.
Chemical & Pharmaceutical Bulletin|July 11, 1998
Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivativesT Okazaki, T Watanabe, K Kikuchi, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1997
Synthesis of novel succinamide derivatives having the 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one skeleton as potent and selective M2 muscarinic receptor antagonists. IT Watanabe, I Kinoyama, A Kakefuda, et al.
Chemical & Pharmaceutical Bulletin|February 20, 1998
Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonistsT Watanabe, A Kakefuda, A Tanaka, et al.
Chemical & Pharmaceutical Bulletin|June 11, 1998
Studies on nonpeptide angiotensin II receptor antagonists. III. Synthesis and biological evaluation of 5-alkylidene-3,5-dihydro-4H-imidazol-4-one derivativesT Okazaki, K Kikuchi, T Watanabe, et al.
Chemical & Pharmaceutical Bulletin|August 6, 1999
Novel potassium channel activators. II. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: modification of the aromatic partY Matsumoto, R Tsuzuki, A Matsuhisa, et al.
Chemical & Pharmaceutical Bulletin|May 1, 1996
Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. II. Synthesis and structure-activity relationships of 4,5,6,7-tetrahydro-1H-benzimidazole derivativesM Ohta, T Suzuki, J Ohmori, et al.
Jinrui Idengaku Zasshi. the Japanese Journal of Human Genetics|December 1, 1989
The characterization of human male-specific 5.7 kb DNA(pKY-1) and its application to fetal sex-determination probeK Nagai, S Koike, R Kominami, et al.
Pageof 5